Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI

  • STATUS
    Recruiting
  • End date
    Nov 1, 2027
  • participants needed
    40
  • sponsor
    James J. Peters Veterans Affairs Medical Center
Updated on 26 December 2021
denosumab
bone mineral density
romosozumab

Summary

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Details
Condition Trauma, Spinal Cord Injuries, Spinal Cord Injury, Wounds, Myelopathy, Osteoporosis, Osteopenia, Spinal Cord Disorders
Treatment Denosumab, Romosozumab
Clinical Study IdentifierNCT05101018
SponsorJames J. Peters Veterans Affairs Medical Center
Last Modified on26 December 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Traumatic motor-complete SCI C4-L2 (AIS grade A & B)
Duration of SCI less than 6 months
Males and females (premenopausal) between the ages of 18 and 50 years old; and a safe range of BMD right above the knee as determined by study staff review

Exclusion Criteria

Active and/or history of coronary heart disease or stroke
Bone cancer
Long-bone fracture of the leg within the past year
History of prior bone disease (for example, Paget's hyperparathyroidism, osteoporosis, etc.)
Postmenopausal women
Men with known low functioning tests before SCI
Drugs geared toward increasing BMD longer than a six month duration after SCI
As determined by study staff review of my medication history of glucocorticoid administration longer than three months duration within the last year
Abnormalities of my endocrine glands such as hyperthyroidism, Cushing's disease or syndrome, etc
Severe underlying chronic disease (for example chronic obstructive pulmonary disease (COPD), end-stage heart disease, chronic renal failure)
Heterotopic ossification (HO) of the distal femur (the knee end of the thigh bone). HO is a condition where bone tissue forms outside of the skeleton. If HO is found in any other area than the distal femur it will not prevent my participation in the study
History of chronic alcohol abuse
Diagnosis of hypercalcemia (high levels of calcium in the blood)
Pregnancy
As determined by study staff review of my medications a bisphosphonate for heterotopic ossification (HO), or other medications to treat osteoporosis other than calcium and vitamin D
Current diagnosis of cancer or history of cancer
As determined by study staff review of my medications, prescribed moderate or high dose corticosteroids (>40 mg/d prednisone or an equivalent dose of other corticosteroid medication) for longer than one week, not including drug administered to preserve neurological function at the time of acute SCI; and
Life expectancy less than 5 years
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note